181 related articles for article (PubMed ID: 33673623)
1. Quantitative Proteomics Reveals Changes Induced by TIMP-3 on Cell Membrane Composition and Novel Metalloprotease Substrates.
Carreca AP; Pravatà VM; D'Apolito D; Bonelli S; Calligaris M; Monaca E; Müller SA; Lichtenthaler SF; Scilabra SD
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673623
[TBL] [Abstract][Full Text] [Related]
2. Increased TIMP-3 expression alters the cellular secretome through dual inhibition of the metalloprotease ADAM10 and ligand-binding of the LRP-1 receptor.
Scilabra SD; Pigoni M; Pravatá V; Schätzl T; Müller SA; Troeberg L; Lichtenthaler SF
Sci Rep; 2018 Oct; 8(1):14697. PubMed ID: 30279425
[TBL] [Abstract][Full Text] [Related]
3. Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding.
Spanò DP; Scilabra SD
Membranes (Basel); 2022 Feb; 12(2):. PubMed ID: 35207132
[TBL] [Abstract][Full Text] [Related]
4. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
[TBL] [Abstract][Full Text] [Related]
5. Dissecting the interaction between tissue inhibitor of metalloproteinases-3 (TIMP-3) and low density lipoprotein receptor-related protein-1 (LRP-1): Development of a "TRAP" to increase levels of TIMP-3 in the tissue.
Scilabra SD; Yamamoto K; Pigoni M; Sakamoto K; Müller SA; Papadopoulou A; Lichtenthaler SF; Troeberg L; Nagase H; Kadomatsu K
Matrix Biol; 2017 May; 59():69-79. PubMed ID: 27476612
[TBL] [Abstract][Full Text] [Related]
6. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2).
Kveiborg M; Jacobsen J; Lee MH; Nagase H; Wewer UM; Murphy G
Biochem J; 2010 Aug; 430(1):79-86. PubMed ID: 20533908
[TBL] [Abstract][Full Text] [Related]
8. Expression of ADAMs (a disintegrin and metalloproteases) and TIMP-3 (tissue inhibitor of metalloproteinase-3) in human prostatic adenocarcinomas.
Karan D; Lin FC; Bryan M; Ringel J; Moniaux N; Lin MF; Batra SK
Int J Oncol; 2003 Nov; 23(5):1365-71. PubMed ID: 14532978
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Mass Spectrometry-Based Secretome Analysis as a Tool to Investigate Metalloprotease and TIMP Activity.
Yang CY; Troeberg L; Scilabra SD
Methods Mol Biol; 2020; 2043():265-273. PubMed ID: 31463919
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
[TBL] [Abstract][Full Text] [Related]
11. GABA receptors ameliorate Hcy-mediated integrin shedding and constrictive collagen remodeling in microvascular endothelial cells.
Shastry S; Tyagi N; Moshal KS; Lominadze D; Hayden MR; Tyagi SC
Cell Biochem Biophys; 2006; 45(2):157-65. PubMed ID: 16757816
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the catalytic activity of the membrane-anchored metalloproteinase ADAM15 in cell-based assays.
Maretzky T; Yang G; Ouerfelli O; Overall CM; Worpenberg S; Hassiepen U; Eder J; Blobel CP
Biochem J; 2009 Apr; 420(1):105-13. PubMed ID: 19207106
[TBL] [Abstract][Full Text] [Related]
13. Cell cholesterol modulates metalloproteinase-dependent shedding of low-density lipoprotein receptor-related protein-1 (LRP-1) and clearance function.
Selvais C; D'Auria L; Tyteca D; Perrot G; Lemoine P; Troeberg L; Dedieu S; Noël A; Nagase H; Henriet P; Courtoy PJ; Marbaix E; Emonard H
FASEB J; 2011 Aug; 25(8):2770-81. PubMed ID: 21518850
[TBL] [Abstract][Full Text] [Related]
14. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
Kwak HI; Mendoza EA; Bayless KJ
Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
[TBL] [Abstract][Full Text] [Related]
15. Quantitative Proteomics Reveals That ADAM15 Can Have Proteolytic-Independent Functions in the Steady State.
Yang CY; Bonelli S; Calligaris M; Carreca AP; Müller SA; Lichtenthaler SF; Troeberg L; Scilabra SD
Membranes (Basel); 2022 May; 12(6):. PubMed ID: 35736286
[TBL] [Abstract][Full Text] [Related]
16. Meprin β induces activities of A disintegrin and metalloproteinases 9, 10, and 17 by specific prodomain cleavage.
Wichert R; Scharfenberg F; Colmorgen C; Koudelka T; Schwarz J; Wetzel S; Potempa B; Potempa J; Bartsch JW; Sagi I; Tholey A; Saftig P; Rose-John S; Becker-Pauly C
FASEB J; 2019 Nov; 33(11):11925-11940. PubMed ID: 31381863
[TBL] [Abstract][Full Text] [Related]
17. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
Milner JM; Rowan AD; Cawston TE; Young DA
Arthritis Res Ther; 2006; 8(5):R142. PubMed ID: 16919164
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1.
Scilabra SD; Troeberg L; Yamamoto K; Emonard H; Thøgersen I; Enghild JJ; Strickland DK; Nagase H
J Biol Chem; 2013 Jan; 288(1):332-42. PubMed ID: 23166318
[TBL] [Abstract][Full Text] [Related]
19. Secretome analysis to elucidate metalloprotease-dependent ectodomain shedding of glycoproteins during neuronal differentiation.
Tsumagari K; Shirakabe K; Ogura M; Sato F; Ishihama Y; Sehara-Fujisawa A
Genes Cells; 2017 Feb; 22(2):237-244. PubMed ID: 28084684
[TBL] [Abstract][Full Text] [Related]
20. Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.
Nakamura H; Suenaga N; Taniwaki K; Matsuki H; Yonezawa K; Fujii M; Okada Y; Seiki M
Cancer Res; 2004 Feb; 64(3):876-82. PubMed ID: 14871815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
